Inactive Instrument

Company Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE

Equities

REKA

IL0010810096

Pharmaceuticals

Business Summary

Rekah Pharmaceutical Industry Ltd. (Rekah) is an Israel-based company which operates directly and through its subsidiaries. The Company operates two Good Manufacturing Practice (GMP) approved manufacturing sites, it has a marketing and distribution arm, a chain of pharmacies, and an export import unit. Rekah's plant covers approximately 5,000 square meters and was designed to take advantage of the most advanced and automated packaging techniques available. In April 1995, Rekah received the approval of the Ministry of Health for its new facility. The sterile department was designed to meet the standard of the United States Food and Drug Administration and was opened in February 1997. The Company distributes its products through Ophir & Shalpharm to institutional users such as Israel Health Funds, hospitals and government health facilities. Other subsidiaries include Vitamed Pharmaceutical Industry Ltd., CenterPharm, RITE, Talmor, BARBARA WOLF Ltd. and Madad.

Sales per Business

ILS in Million2021Weight2022Weight Delta
Core Products
64.8 %
161 60.9 % 190 64.8 % +17.90%
Distribution Special
29.8 %
88 33.5 % 87 29.8 % -1.33%
Other
5.4 %
15 5.6 % 16 5.4 % +5.64%

Sales per region

ILS in Million2021Weight2022Weight Delta
Israel
100.0 %
264 100.0 % 292 100.0 % +10.78%

Managers

Managers TitleAgeSince
Chief Executive Officer 80 23/08/93
Director of Finance/CFO 44 31/10/18
Director/Board Member 78 23/08/93
Corporate Officer/Principal - -
Sales & Marketing 51 12/09/18
Corporate Officer/Principal 47 30/03/11
Corporate Officer/Principal 66 08/01/97
Comptroller/Controller/Auditor 65 14/06/14

Members of the board

Members of the board TitleAgeSince
Director/Board Member 62 14/04/15
Director/Board Member 52 14/04/15
Chairman 77 14/04/15
Chief Executive Officer 80 23/08/93
Director/Board Member 78 23/08/93
Director/Board Member 64 14/04/15
Director/Board Member 55 31/10/16
Director/Board Member 70 31/10/16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,523,922 2,000,627 ( 17.36 %) 19,900 ( 0.1727 %) 17.36 %

Shareholders

NameEquities%Valuation
First Israel Mezzanine Investors Ltd.
42.66 %
4,915,784 42.66 % 18 M ₪
1,748,439 15.17 % 7 M ₪
1,748,439 15.17 % 7 M ₪
Udi Dor
6.876 %
792,374 6.876 % 3 M ₪
Helen Dor
2.710 %
312,329 2.710 % 1 M ₪
Excellence Nessuah Mutual Funds Management Ltd.
1.196 %
137,797 1.196 % 517 534 ₪
IBI Mutual Funds Management (1978) Ltd.
1.151 %
132,685 1.151 % 498 334 ₪
Vitamed Pharmaceutical Industries Ltd.
0.9483 %
109,286 0.9483 % 410 453 ₪
Lamashkia Mutual Funds Management Co. (1982) Ltd.
0.4900 %
56,464 0.4900 % 212 066 ₪
Ramco Mutual Funds Management (1989) Ltd.
0.3471 %
40,000 0.3471 % 150 231 ₪

Company contact information

Rekah Pharmaceutical Industry Ltd.

30 Hamelacha Street

5881904, Holon

+

http://www.rekah.co.il
address Rekah Pharmaceutical Industry Ltd.(REKA)
  1. Stock Market
  2. Equities
  3. REKA Stock
  4. REKA Stock
  5. Company Rekah Pharmaceutical Industry Ltd.